biodefence

Showing 2 posts of 2 posts found.

Nerve gas antidote completes phase I trial

June 9, 2010
Research and Development Protalix, biodefence

Israeli biotech firm Protalix has completed a phase I clinical trial for its intravenous nerve gas antidote. The drug is …

Merck joins coalition for biosecurity vaccine plant

March 22, 2010
Manufacturing and Production, Research and Development biodefence, vaccines

Merck & Co will join in a new US project to create a vaccine research and manufacturing facility designed to …

The Gateway to Local Adoption Series

Latest content